Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (141-150 of 349) with videos related to

Pageof 35
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.
Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2010
Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsJong-Mu Sun, Mi Hyun Nam, Jae Yong Chung, et al.
Clinical Genitourinary Cancer|October 12, 2015
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial CarcinomaYoung Saing Kim, Soon Il Lee, Se Hoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Biomaterials|October 30, 2015
Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cellsChang Eun Yoo, Hui-Sung Moon, Yeon Jeong Kim, et al.
Japanese Journal of Clinical Oncology|February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practiceJiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
Pageof 35

Showing results (141-150 of 349) with videos related to

Sort By:
Pageof 35
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.
Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2010
Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsJong-Mu Sun, Mi Hyun Nam, Jae Yong Chung, et al.
Clinical Genitourinary Cancer|October 12, 2015
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial CarcinomaYoung Saing Kim, Soon Il Lee, Se Hoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Biomaterials|October 30, 2015
Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cellsChang Eun Yoo, Hui-Sung Moon, Yeon Jeong Kim, et al.
Japanese Journal of Clinical Oncology|February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practiceJiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.
Pageof 35